FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034178419> ?p ?o ?g. }

• W2034178419 abstract "One focus in the medical care of HIV-infected patients today is cardiovascular risk reduction. Metabolic disturbances occur frequently in patients taking protease inhibitors (PI) and are a major risk factor for atherosclerosis. With few published head-to-head studies substance-specific differences concerning metabolic effects are insufficiently defined. Therefore this cohort study directly compared the metabolic profiles of boosted atazanavir (ATV/r), fosamprenavir (FPV/r) and saquinavir (SQV/r).Data from a cohort of 124 HIV patients initiating a boosted regimen with one of the PIs at the University of Munich (LMU) infectious diseases outpatient clinic were retrospectively analyzed. The main outcome measures were median absolute total cholesterol levels and median relative change of total cholesterol levels after six months of PI-therapy. A multivariate linear regression model was built to identify and control for potential confounders of the association between PI-therapy and serum cholesterol level.84 patients were treated with ATV/r, 23 patients received FPV/r and 17 patients SQV/r. Demographically the cohort constituted a representative sample of HIV-infected patients in Germany. There were no statistically significant differences between the comparison groups at baseline. - After six months of therapy median serum cholesterol in the ATV/r group dropped significantly from 204 mg/dl to 186 mg/dl, while in the FPV/r and SQV/r groups a rise in serum cholesterol levels was observed from 179 mg/dl to 204 mg/dl and from 173 mg/dl to 209 mg/dl respectively. The multivariate linear regression model identified a significant interaction between BMI at baseline and treatment with FPV/r: patients with higher BMI showed more prominent increases in serum cholesterol while taking FPV/r compared to patients with lower BMI.This cohort study demonstrated the most favourable impact on serum cholesterol levels and thus cardiovascular risk for ATV/r compared to FPV/r and SQV/r under real-life conditions. Given the statistical interaction detected between FPV/r and BMI further studies assessing metabolic profiles of different antiretroviral drugs in specific patient populations are urgently needed." @default.
• W2034178419 created "2016-06-24" @default.
• W2034178419 creator A5017478813 @default.
• W2034178419 creator A5026106874 @default.
• W2034178419 creator A5044030297 @default.
• W2034178419 date "2011-01-01" @default.
• W2034178419 modified "2023-09-29" @default.
• W2034178419 title "Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients" @default.
• W2034178419 cites W1971758213 @default.
• W2034178419 cites W1973787553 @default.
• W2034178419 cites W1976641979 @default.
• W2034178419 cites W1987260222 @default.
• W2034178419 cites W1996083965 @default.
• W2034178419 cites W1996597301 @default.
• W2034178419 cites W2001939836 @default.
• W2034178419 cites W2002147948 @default.
• W2034178419 cites W2015990374 @default.
• W2034178419 cites W2026620011 @default.
• W2034178419 cites W2045131275 @default.
• W2034178419 cites W2052991207 @default.
• W2034178419 cites W2053382469 @default.
• W2034178419 cites W2057504223 @default.
• W2034178419 cites W2062974928 @default.
• W2034178419 cites W2066267771 @default.
• W2034178419 cites W2085301673 @default.
• W2034178419 cites W2088008322 @default.
• W2034178419 cites W2091326103 @default.
• W2034178419 cites W2107165713 @default.
• W2034178419 cites W2107732097 @default.
• W2034178419 cites W2109350540 @default.
• W2034178419 cites W2112402451 @default.
• W2034178419 cites W2123289485 @default.
• W2034178419 cites W2133955454 @default.
• W2034178419 cites W2138467463 @default.
• W2034178419 cites W2147357250 @default.
• W2034178419 cites W2148825772 @default.
• W2034178419 cites W2153788691 @default.
• W2034178419 cites W2159584933 @default.
• W2034178419 cites W2168784348 @default.
• W2034178419 cites W2171236519 @default.
• W2034178419 cites W2602370361 @default.
• W2034178419 cites W4234806062 @default.
• W2034178419 cites W4238251256 @default.
• W2034178419 cites W4240153861 @default.
• W2034178419 cites W4296391115 @default.
• W2034178419 doi "https://doi.org/10.1186/2047-783x-16-2-85" @default.
• W2034178419 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3353428" @default.
• W2034178419 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21463988" @default.
• W2034178419 hasPublicationYear "2011" @default.
• W2034178419 type Work @default.
• W2034178419 sameAs 2034178419 @default.
• W2034178419 citedByCount "5" @default.
• W2034178419 countsByYear W20341784192012 @default.
• W2034178419 countsByYear W20341784192013 @default.
• W2034178419 countsByYear W20341784192014 @default.
• W2034178419 countsByYear W20341784192022 @default.
• W2034178419 crossrefType "journal-article" @default.
• W2034178419 hasAuthorship W2034178419A5017478813 @default.
• W2034178419 hasAuthorship W2034178419A5026106874 @default.
• W2034178419 hasAuthorship W2034178419A5044030297 @default.
• W2034178419 hasBestOaLocation W20341784191 @default.
• W2034178419 hasConcept C126322002 @default.
• W2034178419 hasConcept C127413603 @default.
• W2034178419 hasConcept C142462285 @default.
• W2034178419 hasConcept C167135981 @default.
• W2034178419 hasConcept C201903717 @default.
• W2034178419 hasConcept C203014093 @default.
• W2034178419 hasConcept C2776937687 @default.
• W2034178419 hasConcept C2777275308 @default.
• W2034178419 hasConcept C2778414717 @default.
• W2034178419 hasConcept C2781143361 @default.
• W2034178419 hasConcept C2781413609 @default.
• W2034178419 hasConcept C2993143319 @default.
• W2034178419 hasConcept C3013748606 @default.
• W2034178419 hasConcept C71924100 @default.
• W2034178419 hasConcept C72563966 @default.
• W2034178419 hasConcept C77350462 @default.
• W2034178419 hasConcept C78519656 @default.
• W2034178419 hasConceptScore W2034178419C126322002 @default.
• W2034178419 hasConceptScore W2034178419C127413603 @default.
• W2034178419 hasConceptScore W2034178419C142462285 @default.
• W2034178419 hasConceptScore W2034178419C167135981 @default.
• W2034178419 hasConceptScore W2034178419C201903717 @default.
• W2034178419 hasConceptScore W2034178419C203014093 @default.
• W2034178419 hasConceptScore W2034178419C2776937687 @default.
• W2034178419 hasConceptScore W2034178419C2777275308 @default.
• W2034178419 hasConceptScore W2034178419C2778414717 @default.
• W2034178419 hasConceptScore W2034178419C2781143361 @default.
• W2034178419 hasConceptScore W2034178419C2781413609 @default.
• W2034178419 hasConceptScore W2034178419C2993143319 @default.
• W2034178419 hasConceptScore W2034178419C3013748606 @default.
• W2034178419 hasConceptScore W2034178419C71924100 @default.
• W2034178419 hasConceptScore W2034178419C72563966 @default.
• W2034178419 hasConceptScore W2034178419C77350462 @default.
• W2034178419 hasConceptScore W2034178419C78519656 @default.
• W2034178419 hasLocation W20341784191 @default.
• W2034178419 hasLocation W20341784192 @default.
• W2034178419 hasLocation W20341784193 @default.
• W2034178419 hasLocation W20341784194 @default.
• W2034178419 hasOpenAccess W2034178419 @default.

• next